Skip to Content
Merck
  • Synergism between apple procyanidins and lysosomotropic drugs: potential in chemoprevention.

Synergism between apple procyanidins and lysosomotropic drugs: potential in chemoprevention.

Anticancer research (2006-11-11)
Nikolaus Seiler, Mehdi Chaabi, Stamatiki Roussi, Francine Gossé, Annelise Lobstein, Francis Raul
ABSTRACT

Procyanidins are apple constituents with potential in colon cancer chemoprevention. Human colon cancer derived metastatic cells (SW620), growing under standardized conditions, were exposed to procyanidins and lysosomotropic compounds. Growth, apoptosis and lysosomal integrity was determined using published methods. Lysosomotropic drugs (MDL 72527, phenylalanine methylester and chloroquine) amplified procyanidin-induced growth inhibition and apoptosis in SW620 cells at non-cytotoxic concentrations. The improved toxicity of the drug combinations relies primarily on the enhancement of lysosomal membrane permeability. Combinations with non-toxic concentrations of lysosomotropic compounds improve the anti-carcinogenic properties of apple procyanidins.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
D-Phenylalanine methyl ester hydrochloride, 98%
Sigma-Aldrich
MDL 72527, ≥98% (HPLC)
Sigma-Aldrich
L-Phenylalanine methyl ester hydrochloride, 98%
Sigma-Aldrich
L-Phenylalanine methyl ester hydrochloride